1. Home
  2. GSUN vs VRAX Comparison

GSUN vs VRAX Comparison

Compare GSUN & VRAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

GSUN

Golden Sun Education Group Limited

HOLD

Current Price

$0.24

Market Cap

2.7M

Sector

Real Estate

ML Signal

HOLD

VRAX

Virax Biolabs Group Limited

HOLD

Current Price

$2.63

Market Cap

2.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GSUN
VRAX
Founded
1997
2013
Country
China
United Kingdom
Employees
N/A
N/A
Industry
Other Consumer Services
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.7M
2.1M
IPO Year
2020
2021

Fundamental Metrics

Financial Performance
Metric
GSUN
VRAX
Price
$0.24
$2.63
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$1.00
AVG Volume (30 Days)
5.2M
35.4K
Earning Date
02-13-2026
06-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$217,274.83
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.17
$0.10
52 Week High
$2.85
$13.19

Technical Indicators

Market Signals
Indicator
GSUN
VRAX
Relative Strength Index (RSI) N/A 40.06
Support Level N/A $0.18
Resistance Level N/A $2.92
Average True Range (ATR) 0.00 0.15
MACD 0.00 -0.03
Stochastic Oscillator 0.00 30.32

Price Performance

Historical Comparison
GSUN
VRAX

About GSUN Golden Sun Education Group Limited

Golden Sun Technology Group Ltd operates two principal lines of business: tutorial services and e-commerce services. The company's e-commerce operations currently consist of data analytics-driven marketing and social media promotional services for small and medium-sized businesses on short video platforms based in China. The company's education centers offer two main programs, comprising of foreign language tutorial programs in less commonly taught languages, including, among other things, Spanish and Japanese, provided to individual students as well as to companies and other organizations; and Gaokao repeater tutorial programs, provided to individual students.

About VRAX Virax Biolabs Group Limited

Virax Biolabs Group Ltd is a biotechnology company focused on the detection of immune responses and the development of immune profiling and in vitro diagnostic technologies for viral and immune-mediated diseases, with a current strategic focus on post-acute infection syndromes (PAIS) and related areas of chronic immune dysfunction. The company's principal development activities are centered on T cell-based in vitro diagnostics and immune profiling. The company's flagship product candidate, ViraxImmune, is an in-development T cell-based assay and immune profiling platform intended to support the assessment of immune dysfunction, initially in PAIS indications.

Share on Social Networks: